Mark Olson

Mark Olson, MPH, CCRC, currently serves as the Manager of the Clinical Trials Platform and Regulatory Specialist at BAMF Health since November 2022. Previous experience includes roles as Clinical Research Specialist II and Clinical Research Specialist I at Spectrum Health from December 2020 to November 2022, and Research Associate at NeuMoDx Molecular, a QIAGEN company, from December 2018 to June 2020. Mark also interned as an Epidemiologist at Kent County Health Department in late 2016 and worked as a Lab Manager at Michigan State University from December 2009 to June 2017. Earlier career experience includes a position as Research Specialist at the University of Illinois at Chicago from May 2008 to November 2009. Mark Olson holds a Master of Public Health from Michigan State University College of Human Medicine and a Bachelor of Science in Cellular and Molecular Biology from the University of Illinois Urbana-Champaign.